Anna Więckowska

4.9k total citations · 3 hit papers
64 papers, 3.7k citations indexed

About

Anna Więckowska is a scholar working on Pharmacology, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Anna Więckowska has authored 64 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 29 papers in Computational Theory and Mathematics and 25 papers in Molecular Biology. Recurrent topics in Anna Więckowska's work include Cholinesterase and Neurodegenerative Diseases (32 papers), Computational Drug Discovery Methods (29 papers) and Alzheimer's disease research and treatments (10 papers). Anna Więckowska is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (32 papers), Computational Drug Discovery Methods (29 papers) and Alzheimer's disease research and treatments (10 papers). Anna Więckowska collaborates with scholars based in Poland, Slovenia and Germany. Anna Więckowska's co-authors include Ariel E. Feldstein, Arthur J. McCullough, Nizar N. Zein, Rocío López, Ariel E. Feldstein, Barbara Malawska, Yao‐Chang Liu, Lisa Yerian, Marek Bajda and Bettina G. Papouchado and has published in prestigious journals such as Nucleic Acids Research, Hepatology and PEDIATRICS.

In The Last Decade

Anna Więckowska

61 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis

2009 520 citations Anna Więckowska et al. profile →
In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

2006 509 citations Anna Więckowska et al. profile →
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis

2008 481 citations Anna Więckowska et al. profile →

Peers

Countries citing papers authored by Anna Więckowska

Since Specialization

Citations

This map shows the geographic impact of Anna Więckowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Więckowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Więckowska more than expected).

Fields of papers citing papers by Anna Więckowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Więckowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Więckowska. The network helps show where Anna Więckowska may publish in the future.

Co-authorship network of co-authors of Anna Więckowska

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Więckowska. A scholar is included among the top collaborators of Anna Więckowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Więckowska. Anna Więckowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of new dual butyrylcholinesterase (BuChE) inhibitors and 5-HT7 receptor antagonists as compounds used to treat Alzheimer’s disease symptoms 2025 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), Jolanta Jaśkowska, Grzegorz Satała, Paula Zaręba, Anna Więckowska, Modesto de Candia, Rosa Purgatorio, Anna Boguszewska‐Czubara, (unknown), Gniewomir Latacz, Damian Plażuk	3
2	Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT_1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity 2025 ·Journal of Medicinal Chemistry ·Joanna Śniecikowska, Monika Głuch‐Lutwin, Adam Bucki, (unknown), Krzysztof Więckowski, Justyna Godyń, Anna Więckowska, Agata Siwek, Magdalena Jastrzębska‐Więsek, Anna Partyka, (unknown), Anna Wesołowska, Adrian Newman‐Tancredi, Marcin Kołaczkowski	0
3	4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases 2024 ·ACS Chemical Neuroscience ·(unknown), (unknown), Justyna Godyń, (unknown), Marek Bajda, Tadeusz Karcz, (unknown), Holger Stark, Anna Więckowska, Krzysztof Walczyński, (unknown)	5
4	Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation 2024 ·ACS Chemical Neuroscience ·(unknown), Tomasz Wichur, (unknown), (unknown), Monika Głuch‐Lutwin, Barbara Mordyl, Ewelina Honkisz-Orzechowska, (unknown), Justyna Godyń, Dawid Panek, Paula Zaręba, (unknown), Paweł Żmudzki, Gniewomir Latacz, Katarzyna Pustelny, Adam Bucki, Anna Czarna, Filipe Menezes, Anna Więckowska	5
5	Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies 2023 ·European Journal of Medicinal Chemistry ·Dawid Panek, Anna Pasieka, Gniewomir Latacz, Paula Zaręba, (unknown), Justyna Godyń, (unknown), Florian Nachon, Xavier Brazzolotto, (unknown), Maria Walczak, (unknown), Kinga Sałat, Georg Höfner, Klaus T. Wanner, Anna Więckowska, Barbara Malawska	9
6	Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives 2023 ·Molecules ·Dorota Łażewska, (unknown), Paula Zaręba, Justyna Godyń, (unknown), Ewelina Honkisz-Orzechowska, (unknown), Anna Więckowska, Holger Stark, Katarzyna Kieć‐Kononowicz	4
7	Bacterial type I signal peptidase inhibitors - Optimized hits from nature 2022 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Anders Karlén, Sherry L. Mowbray, Anna Więckowska	14
8	Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease 2022 ·International Journal of Molecular Sciences ·Krzysztof Więckowski, (unknown), (unknown), Tomasz Wichur, (unknown), (unknown), Joanna Śniecikowska, Gniewomir Latacz, Agata Siwek, Justyna Godyń, Adam Bucki, Marcin Kołaczkowski, Anna Więckowska	7
9	Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents 2021 ·ACS Chemical Neuroscience ·Anna Pasieka, Dawid Panek, (unknown), Alba Espargaró, Anna Więckowska, Barbara Malawska, Raimon Sabaté, Marek Bajda	54
10	Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau 2021 ·European Journal of Medicinal Chemistry ·Tomasz Wichur, Anna Pasieka, Justyna Godyń, Dawid Panek, (unknown), Gniewomir Latacz, Ewelina Honkisz-Orzechowska, Adam Bucki, Agata Siwek, Monika Głuch‐Lutwin, Damijan Knez, Xavier Brazzolotto, Stanislav Gobec, Marcin Kołaczkowski, Raimon Sabaté, Barbara Malawska, Anna Więckowska	21
11	In Vitro and In Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases 2020 ·ACS Chemical Neuroscience ·Anna Więckowska, (unknown), (unknown), Adam Bucki, Gniewomir Latacz, Katarzyna Kieć‐Kononowicz, Óscar M. Bautista‐Aguilera, Alejandro Romero, Eva Ramos, Javier Egea, (unknown), Águeda González‐Rodríguez, Francisco López‐Muñoz, Mourad Chioua, José Marco‐Contelles	8
12	Discovery of Novel pERK1/2- or β-Arrestin-Preferring 5-HT _1A Receptor-Biased Agonists: Diversified Therapeutic-like versus Side Effect Profile 2020 ·Journal of Medicinal Chemistry ·Joanna Śniecikowska, Monika Głuch‐Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzębska‐Więsek, Anna Partyka, (unknown), Karolina Pytka, Gniewomir Latacz, (unknown), Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Adrian Newman‐Tancredi, Marcin Kołaczkowski	23
13	Anti‐Alzheimer's multitarget‐directed ligands with serotonin 5‐HT₆ antagonist, butyrylcholinesterase inhibitory, and antioxidant activity 2019 ·Archiv der Pharmazie ·Monika Marcinkowska, Adam Bucki, Dawid Panek, Agata Siwek, (unknown), Marek Bednarski, Małgorzata Zygmunt, Justyna Godyń, (unknown), Magdalena Kotańska, Marcin Kołaczkowski, Anna Więckowska	19
14	Novel Aryloxyethyl Derivatives of 1-(1-Benzoylpiperidin-4-yl)methanamine as the Extracellular Regulated Kinases 1/2 (ERK1/2) Phosphorylation-Preferring Serotonin 5-HT_1A Receptor-Biased Agonists with Robust Antidepressant-like Activity 2019 ·Journal of Medicinal Chemistry ·Joanna Śniecikowska, Monika Głuch‐Lutwin, Adam Bucki, Anna Więckowska, Agata Siwek, Magdalena Jastrzębska‐Więsek, Anna Partyka, (unknown), Karolina Pytka, Krzysztof Pociecha, (unknown), Elżbieta Wyska, Anna Wesołowska, Maciej Pawłowski, Mark A. Varney, Adrian Newman‐Tancredi, Marcin Kołaczkowski	29
15	Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents 2018 ·Molecules ·Dawid Panek, Anna Więckowska, Anna Pasieka, Justyna Godyń, Jakub Jończyk, Marek Bajda, Damijan Knez, Stanislav Gobec, Barbara Malawska	35
16	Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease 2018 ·ACS Chemical Neuroscience ·Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch‐Lutwin, Grzegorz Kazek, Gniewomir Latacz, (unknown), Marcin Kołaczkowski, Jan Korábečný, Ondřej Soukup, Markéta Benková, Katarzyna Kieć‐Kononowicz, Stanislav Gobec, Barbara Malawska	44
17	Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents 2018 ·ACS Chemical Neuroscience ·Dawid Panek, Anna Więckowska, Jakub Jończyk, Justyna Godyń, Marek Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pišlar, Jan Korábečný, Ondřej Soukup, Vendula Šepsová, Raimon Sabaté, Janko Kos, Stanislav Gobec, Barbara Malawska	49
18	Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta 2016 ·Molecules ·(unknown), Marek Bajda, Anna Więckowska, (unknown), Anna Pasieka, Dawid Panek, Justyna Godyń, Tomasz Wichur, Damijan Knez, Stanislav Gobec, Barbara Malawska	29
19	Structure-Based Search for New Inhibitors of Cholinesterases 2013 ·International Journal of Molecular Sciences ·Marek Bajda, Anna Więckowska, (unknown), Natalia Guzior, Christoph Sotriffer, Barbara Malawska	229
20	Novel cholinesterases inhibitors with carbamoyloxyphenyl and N-benzylpiperidine moieties 2008 ·Anna Więckowska	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact